OBJECTIVE: Neuroinflammatory mechanisms are hypothesized to contribute to intracortical microelectrode failures. The cluster of differentiation 14 (CD14) molecule is an innate immunity receptor involved in the recognition of pathogens and tissue damage to promote inflammation. The goal of the study was to investigate the effect of CD14 inhibition on intracortical microelectrode recording performance and tissue integration. APPROACH: Mice implanted with intracortical microelectrodes in the motor cortex underwent electrophysiological characterization for 16 weeks, followed by endpoint histology. Three conditions were examined: (1) wildtype control mice, (2) knockout mice lacking CD14, and (3) wildtype control mice administered a small molecule inhibitor to CD14 called IAXO-101. MAIN RESULTS: The CD14 knockout mice exhibited acute but not chronic improvements in intracortical microelectrode performance without significant differences in endpoint histology. Mice receiving IAXO-101 exhibited significant improvements in recording performance over the entire 16 week duration without significant differences in endpoint histology. SIGNIFICANCE: Full removal of CD14 is beneficial at acute time ranges, but limited CD14 signaling is beneficial at chronic time ranges. Innate immunity receptor inhibition strategies have the potential to improve long-term intracortical microelectrode performance.
OBJECTIVE: Neuroinflammatory mechanisms are hypothesized to contribute to intracortical microelectrode failures. The cluster of differentiation 14 (CD14) molecule is an innate immunity receptor involved in the recognition of pathogens and tissue damage to promote inflammation. The goal of the study was to investigate the effect of CD14 inhibition on intracortical microelectrode recording performance and tissue integration. APPROACH: Mice implanted with intracortical microelectrodes in the motor cortex underwent electrophysiological characterization for 16 weeks, followed by endpoint histology. Three conditions were examined: (1) wildtype control mice, (2) knockout mice lacking CD14, and (3) wildtype control mice administered a small molecule inhibitor to CD14 called IAXO-101. MAIN RESULTS: The CD14 knockout mice exhibited acute but not chronic improvements in intracortical microelectrode performance without significant differences in endpoint histology. Mice receiving IAXO-101 exhibited significant improvements in recording performance over the entire 16 week duration without significant differences in endpoint histology. SIGNIFICANCE: Full removal of CD14 is beneficial at acute time ranges, but limited CD14 signaling is beneficial at chronic time ranges. Innate immunity receptor inhibition strategies have the potential to improve long-term intracortical microelectrode performance.
Authors: T D Y Kozai; T C Marzullo; F Hooi; N B Langhals; A K Majewska; E B Brown; D R Kipke Journal: J Neural Eng Date: 2010-07-19 Impact factor: 5.379
Authors: C S Bjornsson; S J Oh; Y A Al-Kofahi; Y J Lim; K L Smith; J N Turner; S De; B Roysam; W Shain; S J Kim Journal: J Neural Eng Date: 2006-06-21 Impact factor: 5.379
Authors: Kelsey A Potter; Mehdi Jorfi; Kyle T Householder; E Johan Foster; Christoph Weder; Jeffrey R Capadona Journal: Acta Biomater Date: 2014-01-24 Impact factor: 8.947
Authors: A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler Journal: Science Date: 1998-12-11 Impact factor: 47.728
Authors: Jozsef Csicsvari; Darrell A Henze; Brian Jamieson; Kenneth D Harris; Anton Sirota; Péter Barthó; Kensall D Wise; György Buzsáki Journal: J Neurophysiol Date: 2003-08 Impact factor: 2.714
Authors: Monika Goss-Varley; Andrew J Shoffstall; Keith R Dona; Justin A McMahon; Sydney C Lindner; Evon S Ereifej; Jeffrey R Capadona Journal: J Vis Exp Date: 2018-08-18 Impact factor: 1.355
Authors: Hillary W Bedell; John K Hermann; Madhumitha Ravikumar; Shushen Lin; Ashley Rein; Xujia Li; Emily Molinich; Patrick D Smith; Stephen M Selkirk; Robert H Miller; Steven Sidik; Dawn M Taylor; Jeffrey R Capadona Journal: Biomaterials Date: 2018-02-13 Impact factor: 12.479
Authors: Shreya Mahajan; John K Hermann; Hillary W Bedell; Jonah A Sharkins; Lei Chen; Keying Chen; Seth M Meade; Cara S Smith; Jacob Rayyan; He Feng; Youjoung Kim; Matthew A Schiefer; Dawn M Taylor; Jeffrey R Capadona; Evon S Ereifej Journal: Front Bioeng Biotechnol Date: 2020-05-08
Authors: John K Hermann; Shushen Lin; Arielle Soffer; Chun Wong; Vishnupriya Srivastava; Jeremy Chang; Smrithi Sunil; Shruti Sudhakar; William H Tomaszewski; Grace Protasiewicz; Stephen M Selkirk; Robert H Miller; Jeffrey R Capadona Journal: Front Bioeng Biotechnol Date: 2018-08-14